Dupilumab treatment improves signs, symptoms, and quality of life in children aged 6 months to 11 years with moderate-to-severe atopic dermatitis
a plain language summary.
Siegfried EC, Cork MJ, Lockshin B, Katoh N, Begolka WS, Thomas RB, Prescilla R
Journal of Dermatological TreatmentIn the feed 24 Aug 2026, published online 24 Aug 2026, issue 2026 Dec, added to PubMed 24 Aug 2026
Topics: Atopic dermatitis & eczemaPediatric dermatology
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42635354 · DOI 10.1080/09546634.2026.2705673